Circulating Tumor Cells

 A circulating tumor cell (CTC) may be a cell that has shed into the vasculature or lymphatics from a primary tumor and is carried round the body within the blood circulation. CTCs can extravasate and become seeds for the next growth of additional tumors (metastases) in distant organs, a mechanism that's liable for the overwhelming majority of cancer-related deaths. Currently, there's one FDA-approved method for CTC detection, Cell Search, which is employed to diagnose breast, colorectal, and prostatic adenocarcinoma. They are non-invasive, are often used repeatedly, and supply more useful information on metastatic risk, disease progression, and treatment effectiveness. For example, analysis of blood samples from cancer patients has found a propensity for increased CTC detection because the disease progresses. Blood tests are easy and safe to perform and multiple samples are often appropriated time. By contrast, the analysis of solid tumors necessitates invasive procedures that might limit patient compliance.  The important aspect of the power to prognose the longer term progression of the disease is elimination (at least temporarily) of the necessity for surgery when the repeated CTC counts are low and not increasing; the apparent benefits of avoiding the surgery include avoiding the danger associated with the innate tumor-genicity of cancer surgeries.  On the opposite hand, CTCs are very rare, often present as only a couple of cells per milliliter of blood, which makes their detection rather challenging. In addition, they often express a variety of markers that vary from patient to patient, which makes it difficult to develop techniques with high sensitivity and specificity.

High Impact List of Articles

Relevant Topics in